223 related articles for article (PubMed ID: 30280193)
41. Nrf2/ARE pathway inhibits ROS-induced NLRP3 inflammasome activation in BV2 cells after cerebral ischemia reperfusion.
Xu X; Zhang L; Ye X; Hao Q; Zhang T; Cui G; Yu M
Inflamm Res; 2018 Jan; 67(1):57-65. PubMed ID: 28956063
[TBL] [Abstract][Full Text] [Related]
42. The mechanism of NLRP3 inflammasome initiation: Trimerization but not dimerization of the NLRP3 pyrin domain induces robust activation of IL-1β.
Sušjan P; Roškar S; Hafner-Bratkovič I
Biochem Biophys Res Commun; 2017 Feb; 483(2):823-828. PubMed ID: 28065854
[TBL] [Abstract][Full Text] [Related]
43. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
44. NLRP3: A Novel Mediator in Cardiovascular Disease.
Zhou W; Chen C; Chen Z; Liu L; Jiang J; Wu Z; Zhao M; Chen Y
J Immunol Res; 2018; 2018():5702103. PubMed ID: 29850631
[TBL] [Abstract][Full Text] [Related]
45. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
46. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury.
Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J
Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584
[TBL] [Abstract][Full Text] [Related]
47. The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review.
Ciążyńska M; Olejniczak-Staruch I; Sobolewska-Sztychny D; Narbutt J; Skibińska M; Lesiak A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072753
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
[TBL] [Abstract][Full Text] [Related]
49. Ligustrazine disrupts lipopolysaccharide-activated NLRP3 inflammasome pathway associated with inhibition of Toll-like receptor 4 in hepatocytes.
Zhang F; Jin H; Wu L; Shao J; Wu X; Lu Y; Zheng S
Biomed Pharmacother; 2016 Mar; 78():204-209. PubMed ID: 26898443
[TBL] [Abstract][Full Text] [Related]
50. The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases.
He W; Hu Z; Zhong Y; Wu C; Li J
Mol Neurobiol; 2023 May; 60(5):2520-2538. PubMed ID: 36680735
[TBL] [Abstract][Full Text] [Related]
51. NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain.
Stutz A; Kolbe CC; Stahl R; Horvath GL; Franklin BS; van Ray O; Brinkschulte R; Geyer M; Meissner F; Latz E
J Exp Med; 2017 Jun; 214(6):1725-1736. PubMed ID: 28465465
[TBL] [Abstract][Full Text] [Related]
52. Methods to Study Cell Swelling-Induced Inflammasome Activation.
Compan V; Pelegrín P
Methods Mol Biol; 2018; 1714():191-197. PubMed ID: 29177863
[TBL] [Abstract][Full Text] [Related]
53. Silybin inhibits NLRP3 inflammasome assembly through the NAD
Zhang B; Xu D; She L; Wang Z; Yang N; Sun R; Zhang Y; Yan C; Wei Q; Aa J; Liu B; Wang G; Xie Y
FASEB J; 2018 Feb; 32(2):757-767. PubMed ID: 28970254
[TBL] [Abstract][Full Text] [Related]
54. EV71 3D Protein Binds with NLRP3 and Enhances the Assembly of Inflammasome Complex.
Wang W; Xiao F; Wan P; Pan P; Zhang Y; Liu F; Wu K; Liu Y; Wu J
PLoS Pathog; 2017 Jan; 13(1):e1006123. PubMed ID: 28060938
[TBL] [Abstract][Full Text] [Related]
55. Neuroinflammation and COVID-19 Ischemic Stroke Recovery-Evolving Evidence for the Mediating Roles of the ACE2/Angiotensin-(1-7)/Mas Receptor Axis and NLRP3 Inflammasome.
Che Mohd Nassir CMN; Zolkefley MKI; Ramli MD; Norman HH; Abdul Hamid H; Mustapha M
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328506
[TBL] [Abstract][Full Text] [Related]
56. The NLPR3 inflammasome and obesity-related kidney disease.
Ke B; Shen W; Fang X; Wu Q
J Cell Mol Med; 2018 Jan; 22(1):16-24. PubMed ID: 28857469
[TBL] [Abstract][Full Text] [Related]
57. Cytochrome c Negatively Regulates NLRP3 Inflammasomes.
Shi CS; Kehrl JH
PLoS One; 2016; 11(12):e0167636. PubMed ID: 28030552
[TBL] [Abstract][Full Text] [Related]
58. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
[TBL] [Abstract][Full Text] [Related]
59. Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury.
Gong Z; Pan J; Shen Q; Li M; Peng Y
J Neuroinflammation; 2018 Aug; 15(1):242. PubMed ID: 30153825
[TBL] [Abstract][Full Text] [Related]
60. Leptin promotes IL‑18 secretion by activating the NLRP3 inflammasome in RAW 264.7 cells.
Fu S; Liu L; Han L; Yu Y
Mol Med Rep; 2017 Dec; 16(6):9770-9776. PubMed ID: 29039567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
